Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.
Journal: Human pathology
Published: May 11, 2026
Leveraging Open-Source Solutions to Build a Low-Cost Digital Pathology Pipeline for Translational Research.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
An Update on the Activities of the International Society for Laboratory Hematology, 2026.
Journal: International journal of laboratory hematology
Published: April 09, 2026
Characterization of CD123 expression by mast cells in systemic mastocytosis with multicolor flow cytometry.
Journal: Cytometry. Part B, Clinical cytometry
Published: January 07, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement.
Journal: NEJM evidence
Published: August 26, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group.
Journal: American journal of hematology
Published: June 25, 2025
Chronic Anaphylaxis With Indolent Systemic Mastocytosis: A Case Report.
Journal: Case reports in hematology
Published: May 19, 2025
An Approach to the Bone Marrow Workup and Diagnosis of Eosinophilia and Mast Cell Disorders.
Journal: Advances in anatomic pathology
Published: March 27, 2025
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study.
Journal: Journal of the American Academy of Dermatology
Published: March 24, 2025
Last Updated: 09/26/2026